CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Shares withheld for taxes President and CEO gave up 1,375 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - New Bus Dev & Spec Sales gave up 600 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Ops & Prod Dev gave up 253 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 38,236 shares at an average $62.33 ($2,383,193)
- 4 Open-market sale Director sold 62,431 shares at an average $62.07 ($3,874,951)
- 4 Open-market sale Director sold 33,200 shares at $62.09 ($2,061,388)
- 4 Shares withheld for taxes SVP - New Bus Dev & Spec Sales gave up 247 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,611 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Ops & Prod Dev gave up 115 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Ops & Prod Dev gave up 144 shares (to pay taxes)
- 4 Grant or award Vice President and CFO acquired 8,000 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 2,014 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - New Bus Dev & Spec Sales gave up 391 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - New Bus Dev & Spec Sales gave up 546 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 2,550 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President and CFO gave up 507 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Ops & Prod Dev gave up 278 shares (to pay taxes)
Page 22 of 42 · 835 filings